Разширено търсене
Автор да съдържа V. Goranova-Marinova
Каталог "Библиографии" | Списание
Serum levels of OPG and RANKL/OPG ratios in newly-diagnosed patients with multiple myeloma. Clinical correlations
V. Goranova-Marinova; S. Goranov; P. Pavlov;
T. Tzvetkova
и др.
Каталог "Библиографии" | Списание
Comparative analisys of the staging systems of Durie&Salmon and International Staging System(ISS) in patients with multiple myeloma
V. Goranova-Marinova; P. Georgiev; K. Sotirova;
E. Spasov;
I. Hristova;
M. Dimitrova;
K. Sapunarova
и др.
Каталог "Библиографии" | Списание
Therapeutic response in patients with macrofocal form of multiple myeloma, treated with bortezomib-containing regimens
V. Goranova-Marinova; A. Nedeva; P. Georgiev;
I. Hristova;
R. Stanchev;
J. Rajnov;
St. Goranov
и др.
Каталог "Библиографии" | Списание
Therapeutic response and survival in patients, treated with Bortezomib - Based regimens
Каталог "Библиографии" | Списание
Intravascular diffuse large B cell lymphoma case - Report and literature review
Каталог "Библиографии" | Списание
Myeloid sarcoma of the pancreatic head case report and literature review
Каталог "Библиографии" | Списание
Acute panmyelosis with myelofibrosis case report and literature review
Каталог "Библиографии" | Списание
The pathogenetic interrelations between bone and renal damages in patients with multiple myeloma are of a "vicious circle" type
S. Goranov; V. Goranova-Marinova
Каталог "Библиографии" | Списание
Reversal of the renal failure after therapy with bortezomib in patients with multiple myeloma
A. Nedeva; V. Goranova-Marinova; P. Georgiev;
I. Hristova;
J. Raynov;
S. Goranov;
I. Gigov;
I. Nikolov
и др.
Каталог "Библиографии" | Списание
Bisphosphonate-associated osteonecrosis of the jaws - report of three cases in Bulgaria and review of the literature
P. Pechalova; A. Bakardjiev; V. Goranova-Marinova;
S. Goranov
и др.
Каталог "Библиографии" | Списание
The ageing patient with haemophilia
M. Canaro; V. Goranova-Marinova; E. Berntorp
Каталог "Библиографии" | Списание
Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma
H. Avet-Loiseau; V. Goranova-Marinova; et al.
Каталог "Библиографии" | Списание
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.
Meletios A. Dimopoulos; V. Goranova-Marinova; et al.
Каталог "Библиографии" | Списание
Hemolysis related to intravenous immunoglobulins is dependent on the presence of anti-blood group A and B antibodies and individual susceptibility
O. Mielke; S. Fontana; V. Goranova-Marinova;
et al.
и др.
Каталог "Библиографии" | Списание
Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup
H. Ludwig; V. Goranova-Marinova; et al.
Каталог "Библиографии" | Списание
Carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR
W.-J. Chng; V. Goranova-Marinova; et al.
Каталог "Библиографии" | Списание
Carfilzomib-lenalidomide-dexamethasone vs lenalidomide- dexamethasone in relapsed multiple myeloma by previous treatment
Meletios A. Dimopoulos; V. Goranova-Marinova; et al.
Каталог "Библиографии" | Списание
Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study
P. Moreau; V. Goranova-Marinova; et al.
Каталог "Библиографии" | Списание
Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial
S. Grosicki; V. S. Goranova-Marinova; et al.